Abstract
Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have